Effects of the chemically synthesized flavanone 7-(O-prenyl)naringenin-4'-acetate on the estrogen signaling pathway in vivo and in vitro

被引:13
作者
Kretzschmar, Georg [1 ]
Vollmer, Guenter
Schwab, Pia
Tischer, Sandra
Metz, Peter
Zierau, Oliver
机构
[1] Tech Univ Dresden, Inst Zool, D-01062 Dresden, Germany
[2] Tech Univ Dresden, Inst Organ Chem, D-01062 Dresden, Germany
关键词
7-(O-prenyl)naringenin-4'-acetate; flavanones; estrogenic activity; MVLN cells; yeast screen estrogen receptor assay; gene expression; selective estrogen receptor modulators;
D O I
10.1016/j.jsbmb.2007.02.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The flavanone naringenin is known to possess only weak estrogenic properties, but some of its derivatives such as 8-prenylnaringenin are potent pbytoestrogens. The aim of this study was to further clarify structure-function relationships of flavanones regarding their estrogenic or antiestrogenic properties by characterizing the new chemically synthesized naringenin derivative 7-(O-prenyl)naringenin-4'-acetate (7-0-PN). A yeast based reporter gene assay and MVLN cells, a MCF-7-derived cell line that possesses a luciferase reporter gene under the control of a vitellogenin estrogen responsive element, were used to investigate estrogenic actions of 7-0-PN in vitro. Estradiol (E2) has been used as a positive control. Subsequently a 3-day rat uterotrophic assay was performed to test for estrogenic effects. In addition, mRNA expression of estrogen sensitive genes in the uteri of these rats was measured using real time rtPCR. While E2 leads to a strong dose dependent signal in the yeast based reporter gene assay and in NIVLN cells, 7-0-PN shows mild E2 antagonistic properties at concentrations 10(-8) and 10(-7) M, E2 agonistic properties at 10(-6) and 10(-5) M in MVLN cells and no effects on the yeast based system. In contrast to E2 treatment, 7-0-PN treatment did not increase uterus wet weight compared to the negative control. These findings are supported by mRNA expression studies of proliferation markers. Additionally, mRNA expression studies of estrogen regulated genes revealed very strong antiestrogenic properties of 7-0-PN regarding regulation of complement C3 expression while some estrogenic effects could be observed on the expression of estrogen receptor P, clusterin and possibly on progesterone receptor and vascular endothelial growth factor. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 20 条
[1]  
Beral Valerie, 2003, Lancet, V362, P419, DOI 10.1016/S0140-6736(03)14065-2
[2]   MVLN CELLS - A BIOLUMINESCENT MCF-7-DERIVED CELL-LINE TO STUDY THE MODULATION OF ESTROGENIC ACTIVITY [J].
DEMIRPENCE, E ;
DUCHESNE, MJ ;
BADIA, E ;
GAGNE, D ;
PONS, M .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1993, 46 (03) :355-364
[3]   Regulation of gene expression by 8-prenylnaringenin in uterus and liver of Wistar rats [J].
Diel, P ;
Thomae, RB ;
Caldarelli, A ;
Zierau, O ;
Kolba, S ;
Schmidt, S ;
Schwab, P ;
Metz, P ;
Vollmer, G .
PLANTA MEDICA, 2004, 70 (01) :39-44
[4]   An efficient synthesis of the potent phytoestrogens 8-prenylnaringenin and 6-(1,1-dimethylallyl)naringenin by europium(III)-catalyzed Claisen rearrangement [J].
Gester, S ;
Metz, P ;
Zierau, O ;
Vollmer, G .
TETRAHEDRON, 2001, 57 (06) :1015-1018
[5]   Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [J].
Grady, D ;
Herrington, D ;
Bittner, V ;
Blumenthal, R ;
Davidson, M ;
Hlatky, M ;
Hsia, J ;
Hulley, S ;
Herd, A ;
Khan, S ;
Newby, LK ;
Waters, D ;
Vittinghoff, E ;
Wenger, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01) :49-57
[6]   Noncardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [J].
Hulley, S ;
Furberg, C ;
Barrett-Connor, E ;
Cauley, J ;
Grady, D ;
Haskell, W ;
Knopp, R ;
Lowery, M ;
Satterfield, S ;
Schrott, H ;
Vittinghoff, E ;
Hunninghake, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01) :58-66
[7]   REGULATION OF PROGESTERONE-RECEPTOR GENE-EXPRESSION AND GROWTH IN THE RAT UTERUS - MODULATION OF ESTROGEN ACTIONS BY PROGESTERONE AND SEX STEROID-HORMONE ANTAGONISTS [J].
KRAUS, WL ;
KATZENELLENBOGEN, BS .
ENDOCRINOLOGY, 1993, 132 (06) :2371-2379
[8]   No estrogen-like effects of an isopropanolic extract of Rhizoma Cimicifugae racemosae on uterus and vena cava of rats after 17 day treatment [J].
Kretzschmar, G ;
Nisslein, T ;
Zierau, O ;
Vollmer, G .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 97 (03) :271-277
[9]   Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin [J].
Milligan, S ;
Kalita, J ;
Pocock, V ;
Heyerick, A ;
De Cooman, L ;
Rong, H ;
De Keukeleire, D .
REPRODUCTION, 2002, 123 (02) :235-242
[10]  
MILLIGAN SR, 2002, J CLIN ENDOCR METAB, V85, P4912